| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |